Biomea Fusion to release Phase I data for oral GLP-1 drug BMF-650

Go back to Biomea Fusion to release Phase I data for oral GLP-1 drug BMF-650
(NASDAQ: BMEA) Delayed: 0.67 -0.02 (2.9%)
Previous Close $0.69    52 Week High $ 
Open $0.66    52 Week Low $ 
Day High $0.70    P/E N/A 
Day Low $0.66    EPS $ 
Volume 294,397